Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$115.07 +1.13 (+0.99%)
As of: Nov 11, 2026 · 2:35 PM EST

Rhythm Pharmaceuticals (RYTM) Return on Capital Employed [ROCE] (2017 - 2026)

Updated

Rhythm Pharmaceuticals' Return on Capital Employed [ROCE] was -64.72% in Q3 2026, down 9.23 percentage points from -55.50% a year earlier and down 1.27 percentage points from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Return on Capital Employed [ROCE] (2017 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Rhythm Pharmaceuticals came in at -58.14%, up 49.36 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of +1.30 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -107.49% in FY2024 (-46.53 pp), -60.96% in FY2023 (-4.30 pp), -56.66% in FY2022 (+22.48 pp) and -79.14% in FY2021 (-19.71 pp).
  • The Q3 2026 figure marks the lowest quarterly Return on Capital Employed [ROCE] since Q2 2025.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in six of the last eight quarters, with an average year-over-year change of +17.52 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2025 (a gain of 51.64 percentage points); the worst was Q1 2024 (a drop of 56.21 percentage points).
  • Per Business Quant data, RYTM's Return on Capital Employed [ROCE] in the three quarters before Q3 2026 was -63.45% (Q2 2026), -55.12% (Q1 2026) and -49.54% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Rhythm Pharmaceuticals 7.90 Bn 6.52 Bn 79.96 Mn -64.72%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -64.72%
Jun 30, 2026 -63.45%
Mar 31, 2026 -55.12%
Dec 31, 2025 -49.54%
Sep 30, 2025 -55.50%
Jun 30, 2025 -70.90%
Mar 31, 2025 -62.17%
Dec 31, 2024 -101.18%
Sep 30, 2024 -96.51%
Jun 30, 2024 -100.02%
Mar 31, 2024 -112.49%
Dec 31, 2023 -63.95%
Sep 30, 2023 -65.69%
Jun 30, 2023 -64.08%
Mar 31, 2023 -56.28%
Dec 31, 2022 -51.74%
Sep 30, 2022 -62.57%
Jun 30, 2022 -81.55%
Mar 31, 2022 -72.47%
Dec 31, 2021 -56.83%
API Access

Rhythm Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RYTM&period=max&api_key=YOUR_API_KEY